← Medtronic plc

Annual Trend FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 TTM
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net Income (Loss) Attributable to Parent
$4.0b +13.85%
$3.1b -22.94%
$4.6b +49.19%
$4.8b +3.41%
$3.6b -24.70%
$5.0b +39.74%
$3.8b -25.42%
$3.7b -2.18%
$4.7b +26.82%
$4.8b +2.98%
—
Net Income (Loss) Available to Common Stockholders, Basic
$4.0b +13.74%
$3.1b -23.09%
$4.7b +50.24%
$4.8b +3.35%
$3.6b -24.47%
$5.1b +39.45%
$3.8b -25.25%
$3.7b -2.09%
$4.7b +26.61%
$4.8b +3.11%
—
Net Income (Loss) Attributable to Noncontrolling Interest ($4.0m) ($9.0m) $19.0m $17.0m $24.0m $22.0m $26.0m $28.0m $29.0m $37.0m —
Amortization of Debt Issuance Costs and Discounts $11.0m ($13.0m) — — — — — — — — —
Amortization of Intangible Assets $2.0b $1.8b $1.8b $1.8b $1.8b $1.7b $1.7b $1.7b $1.8b $1.8b —
Depreciation $937.0m $821.0m $895.0m $907.0m $919.0m $974.0m $999.0m $954.0m $1.1b $1.2b $1.2b
Depreciation, Depletion and Amortization $2.9b $2.6b $2.7b $2.7b $2.7b $2.7b $2.7b $2.6b $2.9b $3.0b $3.0b
Deferred Income Tax Expense (Benefit) ($876.0m) ($1.1b) ($438.0m) ($1.3b) ($461.0m) ($611.0m) ($253.0m) ($528.0m) ($339.0m) $31.0m $51.0m
Deferred income taxes ($459.0m) ($919.0m) ($304.0m) ($1.3b) ($422.0m) ($604.0m) ($226.0m) ($508.0m) ($316.0m) $51.0m $51.0m
Share-based Payment Arrangement, Expense $348.0m $344.0m $290.0m $297.0m $344.0m $359.0m $355.0m $393.0m $429.0m $457.0m $457.0m
Share-based Payment Arrangement, Noncash Expense $348.0m $344.0m $290.0m $297.0m $344.0m $359.0m $355.0m $393.0m $429.0m $457.0m $457.0m
Stock-based compensation $348.0m $344.0m $290.0m $297.0m $344.0m $359.0m $355.0m $393.0m $429.0m $457.0m $457.0m
Asset impairments and related inventory write-downs — — — $0 $0 $515.0m $0 $371.0m $0 $0 —
Equity Method Investment, Other than Temporary Impairment — — — — — — — — $135.0m $71.0m —
Goodwill, Impairment Loss $0 $0 $0 $0 $0 $0 — $0 $0 $0 $0
Impairment of Intangible Assets, Finite-lived $0 $0 $87.0m $37.0m — — $0 — $0 $0 —
Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) $0 $68.0m $30.0m $35.0m — — — — $0 $0 —
Nonoperating Income (Expense) ($222.0m) ($505.0m) — — — — — — — — —
Other Nonoperating Income (Expense) — — $373.0m $356.0m $336.0m $318.0m $515.0m $412.0m $402.0m $384.0m —
Changes in operating assets and liabilities:
Accounts receivable, net ($75.0m) ($275.0m) ($581.0m) $1.3b ($761.0m) ($477.0m) ($576.0m) ($391.0m) ($433.0m) ($200.0m) ($200.0m)
Increase (Decrease) in Inventories $227.0m $192.0m $274.0m $577.0m ($78.0m) $560.0m $939.0m $139.0m $292.0m $404.0m ($404.0m)
Inventories ($227.0m) ($192.0m) ($274.0m) ($577.0m) $78.0m ($560.0m) ($939.0m) ($139.0m) ($292.0m) ($404.0m) ($404.0m)
Accounts payable and accrued liabilities $356.0m $65.0m $399.0m ($44.0m) $531.0m $213.0m $696.0m $391.0m $209.0m $46.0m —
Other operating assets and liabilities $85.0m $229.0m ($624.0m) ($609.0m) ($549.0m) ($65.0m) ($148.0m) ($345.0m) ($538.0m) ($865.0m) —
Other Operating Income (Expense), Net — — ($258.0m) ($71.0m) ($315.0m) ($862.0m) $131.0m ($464.0m) $23.0m ($386.0m) —
Net Cash Provided by (Used in) Operating Activities
$6.9b +31.85%
$4.7b -31.92%
$7.0b +49.59%
$7.2b +3.24%
$6.2b -13.74%
$7.3b +17.72%
$6.0b -17.79%
$6.8b +12.39%
$7.0b +3.79%
$7.3b +4.06%
$7.3b 0.00%
Cash flows from investing activities:
Payments to Acquire Property, Plant, and Equipment $1.3b $1.1b $1.1b $1.2b $1.4b $1.4b $1.5b $1.6b $1.9b $1.9b ($1.9b)
Payments to Acquire Investments $4.4b $3.2b $2.5b $11.0b $11.8b $9.9b $7.5b $7.7b $8.2b $8.7b ($8.7b)
Purchases of investments ($4.4b) ($3.2b) ($2.5b) ($11.0b) ($11.8b) ($9.9b) ($7.5b) ($7.7b) ($8.2b) ($8.7b) —
Sales and maturities of investments $5.4b $4.2b $4.7b $9.6b $11.3b $9.7b $7.3b $7.4b $8.5b $8.1b —
Acquisitions, net of cash acquired ($1.3b) ($137.0m) ($1.8b) ($488.0m) ($994.0m) ($91.0m) ($1.9b) ($211.0m) ($98.0m) ($406.0m) ($406.0m)
Payments to Acquire Businesses, Net of Cash Acquired $1.3b $137.0m $1.8b $488.0m $994.0m $91.0m $1.9b $211.0m $98.0m $406.0m ($406.0m)
Other investing activities, net $22.0m ($22.0m) $36.0m ($37.0m) ($54.0m) ($10.0m) $4.0m ($261.0m) ($249.0m) ($4.0m) —
Payments for (Proceeds from) Other Investing Activities ($22.0m) $22.0m ($36.0m) $37.0m $54.0m $10.0m ($4.0m) $261.0m $249.0m $4.0m —
Net Cash Provided by (Used in) Investing Activities ($1.6b) $5.9b ($774.0m) ($3.2b) ($2.9b) ($1.7b) ($3.5b) ($2.4b) ($1.9b) ($2.9b) ($2.9b)
Cash flows from financing activities:
Change in current debt obligations, net $906.0m ($249.0m) ($713.0m) ($17.0m) ($311.0m) $0 $0 $1.1b ($1.1b) $9.0m —
Gain (Loss) on Extinguishment of Debt $0 ($38.0m) ($457.0m) ($406.0m) ($308.0m) $0 ($53.0m) $0 $0 — —
Issuance of long-term debt $2.1b $21.0m $7.8b $5.6b $7.2b $0 $5.4b $0 $3.2b $1.7b —
Payments on long-term debt ($863.0m) ($7.4b) ($7.9b) ($6.1b) ($7.4b) ($1.0m) ($6.0b) $0 $0 ($2.9b) —
Repayments of Long-term Debt $863.0m $7.4b $7.9b $6.1b $7.4b $1.0m $6.0b $0 $0 $2.9b ($2.9b)
Payments for Repurchase of Common Stock $3.5b $2.2b $2.9b $1.3b $652.0m $2.5b $645.0m $2.1b $3.2b $1.0b —
Payments of Ordinary Dividends, Common Stock $2.4b $2.5b $2.7b $2.9b $3.1b $3.4b $3.6b $3.7b $3.6b $4k ($3.6b)
Proceeds from Issuance of Common Stock — — — — — — — — — $516.0m $1.1b
Dividends to shareholders ($2k) ($2k) ($3k) ($3k) ($3k) ($3k) ($4k) ($4k) ($4k) ($4k) —
Other financing activities, net $85.0m ($2.0m) $14.0m ($81.0m) ($268.0m) $163.0m ($409.0m) ($3.0m) ($184.0m) $44.0m —
Proceeds from (Payments for) Other Financing Activities $85.0m ($2.0m) $14.0m ($81.0m) ($268.0m) $163.0m ($409.0m) ($3.0m) ($184.0m) $44.0m —
Net Cash Provided by (Used in) Financing Activities
($3.3b) +65.60%
($12.0b) -264.12%
($5.4b) +54.57%
($4.2b) +22.70%
($4.1b) +1.48%
($5.3b) -29.01%
($5.0b) +7.05%
($4.5b) +10.28%
($4.4b) +2.00%
($4.8b) -8.94%
($4.8b) +0.02%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $65.0m $114.0m $724.0m ($253.0m) ($547.0m) $121.0m ($2.2b) ($259.0m) $934.0m ($269.0m) $1.9b
Cash and cash equivalents at beginning of period $2.9b $5.0b $4.4b $4.1b $3.6b $3.7b $1.5b $1.3b $2.2b $1.9b —
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents — — $4.4b $4.1b $3.6b $3.7b $1.5b $1.3b $2.2b $1.9b $1.9b
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents — — ($78.0m) ($86.0m) $215.0m ($231.0m) $243.0m ($230.0m) $188.0m $85.0m $85.0m
Effect of exchange rate changes on cash and cash equivalents $65.0m $114.0m ($78.0m) ($86.0m) $215.0m ($231.0m) $243.0m ($230.0m) $188.0m $85.0m $85.0m
Additional Supplementary Disclosures
Additional Supplementary Disclosures
Additional Financial Items
Equity Securities, FV-NI, Realized Gain (Loss) — — — — — — — — — ($140.0m) —
Fair Value, Option, Changes in Fair Value, Gain (Loss) — — — — — — — ($220.0m) ($171.0m) — —
Foreign Currency Transaction Gain (Loss), before Tax — — — — — — — — — ($57.0m) —
Gain (Loss) Related to Litigation Settlement — — — — — — $30.0m — — — —
Gain (Loss) on Disposition of Business — $697.0m $0 $0 — — — — — — —
Goodwill $38.5b $39.5b $40.0b $39.8b $42.0b $40.5b $41.4b $41.0b $41.7b $42.6b $0
Income Tax Expense (Benefit) $578.0m $2.6b $547.0m ($751.0m) $265.0m $456.0m $1.6b $1.1b $936.0m $1.3b —
Income Taxes Paid, Net $1.0b $2.5b $1.6b $878.0m $1.2b $996.0m $1.5b $1.6b $1.8b $1.9b —
Interest $1.1b $1.1b $973.0m $643.0m $582.0m $540.0m $606.0m $826.0m $762.0m $774.0m $774.0m
Interest Expense Nonoperating — — — — — — — — $729.0m $715.0m —
Issuance of ordinary shares $428.0m $403.0m $992.0m $662.0m $474.0m $429.0m $308.0m $284.0m $508.0m $516.0m —
Net change in cash and cash equivalents $2.1b ($1.3b) $724.0m ($253.0m) ($547.0m) $121.0m ($2.2b) ($259.0m) $934.0m ($269.0m) —
Other, net ($93.0m) $117.0m $257.0m $217.0m $251.0m $138.0m $270.0m $573.0m $310.0m $314.0m —
Proceeds from Contributions from Affiliates $0 $0 $0 — — — — — — — —
Proceeds from MiniMed initial public offering — — — — — — — $0 $0 $538.0m —
Provision for credit losses $39.0m $52.0m $78.0m $99.0m $128.0m $58.0m $73.0m $90.0m $123.0m $136.0m —
Repurchase of ordinary shares ($3.5b) ($2.2b) ($2.9b) ($1.3b) ($652.0m) ($2.5b) ($645.0m) ($2.1b) ($3.2b) ($1.0b) —
Restructuring Costs — — — — — — — — $303.0m $370.0m —
Supplemental disclosure of cash flow information:

Amounts are shown in USD as reported in each fiscal year filing.

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.